We have received text from H.R. 5381: Opioid Treatment Providers Act. This bill was received on 2025-09-16, and currently has no cosponsors.
Here is a short summary of the bill:
This bill, known as the Opioid Treatment Providers Act, aims to make opioid treatment programs eligible for certain federal grants. Specifically, it amends a section of the Social Security Act, allowing opioid treatment programs to receive health professions opportunity grants. Previously, eligibility for these grants was limited to certain organizations, and the bill expands this eligibility to include opioid treatment programs and other high-quality comprehensive addiction care providers.
Key Provisions
- The bill focuses on opioid treatment programs, which are facilities that provide medical care and support services to individuals dealing with opioid addiction.
- It allows these programs to access health professions opportunity grants, which are typically used to support workforce development in health care fields.
- The change enhances the ability of opioid treatment programs to receive funding, potentially improving their services and support for individuals in recovery.
- The amendment officially removes prior restrictions that excluded certain entities from grant eligibility.
Implementation Timeline
- The changes brought by this legislation will take effect on October 1, 2025.
- After this date, qualifying opioid treatment programs can begin to apply for the grants referenced in the amendment.
Goals of the Legislation
- Enhancing access to treatment for individuals with opioid use disorders.
- Supporting the development of a skilled workforce in addiction treatment and recovery services.
- Promoting comprehensive and effective care by expanding funding opportunities for treatment programs.
Relevant Companies
- PFE - Pfizer Inc.: As a major pharmaceutical company, Pfizer may be affected by increased demand for addiction treatment medications and therapies in programs that receive new funding.
- INDV - Indivior PLC: This company specializes in addiction treatment medications and could see an uptick in utilization of its products due to expanded treatment access through federally funded programs.
Representative Thomas R. Suozzi Bill Proposals
Here are some bills which have recently been proposed by Representative Thomas R. Suozzi:
- H.R.5534: To add the Republic of Korea to the E-3 nonimmigrant visa program.
- H.R.5381: Opioid Treatment Providers Act
- H.R.4739: SHARE Plan Act
- H.R.4466: CIRCLE Act
- H.R.4266: Housing for US Act
- H.R.2082: WISH Act
You can track bills proposed by Representative Thomas R. Suozzi on Quiver Quantitative's politician page for Suozzi.
Representative Thomas R. Suozzi Net Worth
Quiver Quantitative estimates that Representative Thomas R. Suozzi is worth $12.2M, as of September 25th, 2025. This is the 96th highest net worth in Congress, per our live estimates.
Suozzi has approximately $9.1M invested in publicly traded assets which Quiver is able to track live.
You can track Representative Thomas R. Suozzi's net worth on Quiver Quantitative's politician page for Suozzi.
Representative Thomas R. Suozzi Stock Trading
We have data on up to $33.6M of trades from Representative Thomas R. Suozzi, which we parsed from STOCK Act filings. Some of the largest trades include:
- A December 1st, 2020 sale of up to $250K of $FCEL. The stock has fallen 96.81% since then.
- A November 18th, 2019 purchase of up to $250K of $TIP. The stock has fallen 4.13% since then.
- A November 24th, 2021 purchase of up to $250K of $MS. The stock has risen 56.13% since then.
- A March 2nd, 2020 sale of up to $250K of $NVDA. The stock has risen 2460.77% since then.
- A June 3rd, 2021 sale of up to $100K of $PTC. The stock has risen 57.12% since then.
You can track Representative Thomas R. Suozzi's stock trading on Quiver Quantitative's politician page for Suozzi.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
